Literature DB >> 3905321

Desensitization with human (recombinant DNA) insulin.

T W Bodendorfer, M E Brown, E H Frankel, B H Palay, S R Fulp.   

Abstract

A 34-year-old woman developed gestational diabetes and was treated with insulin (beef-pork and beef) and oral therapy at various periods. She developed an insulin allergy; however, attempts at desensitization with the commercially available purified pork insulin desensitization kit (Eli Lilly Co.) were not successful. Reactivity to human (recombinant DNA) insulin as well as elevated IgE levels and eosinophilia were also demonstrated. A second desensitization attempt with human (recombinant DNA) insulin using a protocol developed by the authors was successful. This report discusses a desensitization procedure using human insulin in an insulin-allergic patient.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3905321     DOI: 10.1177/106002808501901106

Source DB:  PubMed          Journal:  Drug Intell Clin Pharm        ISSN: 0012-6578


  1 in total

Review 1.  Human insulin. A review of its biological activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.